Skip to main content

Advertisement

SpringerLink
Log in

Clinical and anamnestic features of patients with systemic vasculitis: a single-center retrospective study

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Systemic vasculitides are the most complex and problematic autoimmune rheumatic diseases characterized by affections of large, medium, or small vessels. Although the immunopathogenesis of vasculitides is thoroughly studied, the epidemiology and etiology are poorly explored. The main triggers of vasculitides are environmental, genetic, and various infectious factors. Diagnosis of vasculitides is complicated due to the non-specific nature of their symptoms. Vasculitides affect various organ systems with abrupt or slow (weeks–months) development of symptoms. This study aims to analyze the demographic and clinical-anamnestic characteristics of patients with systemic vasculitides in a single centre before and during the COVID-19 pandemic in Kazakhstan. A single-centre retrospective study of medical records of 80 patients above 18 years was conducted in the Almaty City Rheumatology Center. Medical records of 24 males (30%) and 56 females (70%) with systemic vasculitides, diagnosed from January 2019 to December 2021, were analyzed. Age, gender, damaged organ systems, disability, concomitant diseases, disease experience, laboratory data, and other variables were recorded. The records of hospitalized patients with systemic vasculitides were analyzed. Of 80 patients registered in 2019–2021, the most common were those with IgA vasculitis (n = 32, 40%), Takayasu arteritis (n = 17, 21.25%), and granulomatosis with polyangiitis (n = 12, 15%). Behçet disease was diagnosed less frequently (n = 9, 11.25%). Patients with systemic vasculitides had pre-obesity (n = 19), class 1 obesity (n = 13), and class 2 obesity (n = 2). Musculoskeletal affections were present in 52 patients (65%). Gastrointestinal, cutaneous, and cardiovascular affections were recorded in 45 (56.3%), 37 (46.3%), and 39 (48.8%) cases, respectively. Only 8 patients (10%) had affections of the nervous system. Most patients had elevated C-reactive protein (n = 29, 36.3%) and leukocytosis (n = 33, 41.3%). One-third of patients with vasculitides had a history of abortions. Musculoskeletal, cutaneous, gastrointestinal, and cardiovascular affections are common in patients with systemic vasculitides. Obesity is a frequent comorbidity in vasculitides. Comorbidities and abortions complicate the disease course and its management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Data are available from the corresponding author upon reasonable request.

References

  1. Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, Polimeni A, de Vincentiis M (2020) Pathophysiology and therapy of systemic vasculitides. EXCLI J 19:817–854. https://doi.org/10.17179/excli2020-1512

    Article  PubMed  PubMed Central  Google Scholar 

  2. Micheletti RG (2022) Treatment of cutaneous vasculitis. Front Med (Lausanne) 18(9):1059612. https://doi.org/10.3389/fmed.2022.1059612

    Article  Google Scholar 

  3. Theofilis P, Vordoni A, Koukoulaki M, Vlachopanos G, Kalaitzidis RG (2022) Overview of infections as an etiologic factor and complication in patients with vasculitides. Rheumatol Int 42(5):759–770. https://doi.org/10.1007/s00296-022-05100-9

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715

    Article  CAS  PubMed  Google Scholar 

  5. Genga E, Oyoo O, Adebajo A (2018) Vasculitis in Africa. Curr Rheumatol Rep 20(2):4. https://doi.org/10.1007/s11926-018-0711-y

    Article  PubMed  PubMed Central  Google Scholar 

  6. Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA (2022) DCVAS Investigators. American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 81(3):315–320. https://doi.org/10.1136/annrheumdis-2021-221795

  7. Sreih AG, Cronin K, Shaw DG, Young K, Burroughs C, Kullman J, Machireddy K, McAlear CA, Merkel PA; Vasculitis Patient-Powered Research Network (2021) Diagnostic delays in vasculitis and factors associated with time to diagnosis. Orphanet J Rare Dis. 16(1):184. https://doi.org/10.1186/s13023-021-01794-5

  8. Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N (2019) Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol 39(8):1520–1541. https://doi.org/10.1161/ATVBAHA.118.310957

    Article  CAS  PubMed  Google Scholar 

  9. Watts RA, Hatemi G, Burns JC, Mohammad AJ (2022) Global epidemiology of vasculitis. Nat Rev Rheumatol 18(1):22–34. https://doi.org/10.1038/s41584-021-00718-8

    Article  PubMed  Google Scholar 

  10. Auanassova A, Yessirkepov M, Zimba O (2023) The impact of the COVID-19 pandemic on patients with systemic vasculitis: a single-centre retrospective study. Rheumatol Int 43(3):459–466. https://doi.org/10.1007/s00296-023-05276-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360(9341):1197–1202. https://doi.org/10.1016/S0140-6736(02)11279-7

    Article  PubMed  Google Scholar 

  12. Sapina M, Frkovic M, Sestan M, Srsen S, Ovuka A, Batnozic Varga M, Kramaric K, Brdaric D, Milas K, Gagro A, Jelusic M (2021) Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis. Ann Rheum Dis 80(5):610–616. https://doi.org/10.1136/annrheumdis-2020-218649

    Article  CAS  PubMed  Google Scholar 

  13. Saadoun D, Bura-Riviere A, Comarmond C, Lambert M, Redheuil A, Mirault T (2021) French recommendations for the management of Takayasu’s arteritis. Orphanet J Rare Dis 16(Suppl 3):311. https://doi.org/10.1186/s13023-021-01922-1

    Article  PubMed  PubMed Central  Google Scholar 

  14. Xiang L, Low AHL, Leung YY, Fong W, Gan WH, Graves N, Thumboo J (2020) Work disability in rheumatic diseases: baseline results from an inception cohort. Int J Rheum Dis 8:1040–1049. https://doi.org/10.1111/1756-185X.13864

    Article  Google Scholar 

  15. Onen F, Akkoc N (2017) Epidemiology of Takayasu arteritis. Presse Med 46(7–8 Pt 2):e197–e203. https://doi.org/10.1016/j.lpm.2017.05.034

    Article  PubMed  Google Scholar 

  16. Yelin E (2007) Work disability in rheumatic diseases. Curr Opin Rheumatol 19(2):91–96. https://doi.org/10.1097/BOR.0b013e3280126b66

    Article  PubMed  Google Scholar 

  17. McCormick N, Marra CA, Aviña-Zubieta JA (2017) Productivity losses and costs in the less-common systemic autoimmune rheumatic diseases. Curr Rheumatol Rep 19(11):72. https://doi.org/10.1007/s11926-017-0698-9

    Article  PubMed  Google Scholar 

  18. Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA, Little MA, Jayne DR, Flossmann O, McLaren J, Kumar V, Erwig LP, Reid DM, Macfarlane GJ, Jones GT (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) 53(5):953–956. https://doi.org/10.1093/rheumatology/ket483

    Article  CAS  PubMed  Google Scholar 

  19. Wang CR, Tsai HW (2021) Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol 27(1):19–36. https://doi.org/10.3748/wjg.v27.i1.19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ziade N, El Khoury B, Zoghbi M, Merheb G, Abi Karam G, Mroue’ K, Messaykeh J (2020) Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study. Sci Rep 10(1):7683. https://doi.org/10.1038/s41598-020-64732-8

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kronbichler A, Leierer J, Gauckler P, Shin JI (2020) Comorbidities in ANCA-associated vasculitis. Rheumatology (Oxford) 59(Suppl 3):iii79–iii83. https://doi.org/10.1093/rheumatology/kez617

  22. Gilman C, Heller T, Koh C (2019) Chronic hepatitis delta: a state-of-the-art review and new therapies. World J Gastroenterol 25(32):4580–4597. https://doi.org/10.3748/wjg.v25.i32.4580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Taylor JM (2020) Infection by hepatitis delta virus. Viruses 12(6):648. https://doi.org/10.3390/v12060648

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nikolaishvili M, Pazhava A, Di Lernia V (2023) Viral infections may be associated with Henoch-Schönlein purpura. J Clin Med 12(2):697. https://doi.org/10.3390/jcm12020697

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Prabhahar A, Naidu GSRSNK, Chauhan P, Sekar A, Sharma A, Sharma A, Kumar A, Nada R, Rathi M, Kohli HS, Ramachandran R (2022) ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int 42(4):749–758. https://doi.org/10.1007/s00296-021-05069-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Thomas K, Vassilopoulos D (2017) Infections and vasculitis. Curr Opin Rheumatol 29(1):17–23. https://doi.org/10.1097/BOR.0000000000000348

    Article  CAS  PubMed  Google Scholar 

  27. Lidar M, Lipschitz N, Langevitz P, Shoenfeld Y (2009) The infectious aetiology of vasculitis. Autoimmunity 42(5):432–438. https://doi.org/10.1080/08916930802613210

    Article  PubMed  Google Scholar 

  28. Pagnoux C (2008) Grossesse et vascularites (Pregnancy and vasculitides). Presse Med 37(11):1657–1665. https://doi.org/10.1016/j.lpm.2008.06.016

    Article  PubMed  Google Scholar 

  29. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232. https://doi.org/10.1056/NEJMoa0909905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jones RB, TervaertJW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR; European Vasculitis Study Group (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211–20. https://doi.org/10.1056/NEJMoa0909169

  31. Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, Le Guillou AC, Yakoub-Agha I, Dharancy S, Noel C, Vantyghem MC (2015) Immunosuppressive drugs and fertility. Orphanet J Rare Dis 10:136. https://doi.org/10.1186/s13023-015-0332-8

    Article  PubMed  PubMed Central  Google Scholar 

  32. Pecher AC, Henes M, Henes JC (2023) Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives. Arch Gynecol Obstet 308(2):379–385. https://doi.org/10.1007/s00404-022-06744-5

    Article  PubMed  Google Scholar 

  33. Pedreira ALS, Chagas GP, Santiago MB (2022) Pregnancy in Takayasu arteritis: a cross-sectional study and review of literature. ARP Rheumatol 1(4):300–303

    PubMed  Google Scholar 

  34. Pagnoux C, Mahendira D, Laskin CA (2013) Fertility and pregnancy in vasculitis. Best Pract Res Clin Rheumatol 27(1):79–94. https://doi.org/10.1016/j.berh.2013.02.002

    Article  PubMed  Google Scholar 

  35. Nuttall FQ (2015) Body mass index: obesity, BMI, and health: a critical review. Nutr Today 50(3):117–128. https://doi.org/10.1097/NT.0000000000000092

    Article  PubMed  PubMed Central  Google Scholar 

  36. Garrow JS, Webster J (1985) Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 9(2):147–153

    CAS  PubMed  Google Scholar 

  37. Gendreau S, Porcher R, Thoreau B, Paule R, Maurier F, Goulenok T, Frumholtz L, Bernigaud C, Ingen-Housz-Oro S, Mekinian A, Audemard-Verger A, Gaillet A, Perard L, Samson M, Sonneville R, Arlet JB, Mirouse A, Kahn JE, Charpentier J, Hachulla É, Hummel A, Pires T, Carron PL, Durel CA, Jourde W, Puechal X, Lega JC, Sarrot-Reynauld F, Tieulie N, Diot E, Guillevin L, Terrier B (2021) Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract. Semin Arthritis Rheum 51(2):436–441. https://doi.org/10.1016/j.semarthrit.2021.03.002

    Article  CAS  PubMed  Google Scholar 

  38. Misra DP, Shenoy SN (2017) Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int 37(1):151–167. https://doi.org/10.1007/s00296-016-3435-1

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan

    Akerke Auanassova & Marlen Yessirkepov

Authors
  1. Akerke Auanassova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlen Yessirkepov
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors substantively contributed to the design, execution, and reporting of the study. They take full responsibility for all aspects of the study and writing.

Corresponding author

Correspondence to Akerke Auanassova.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Auanassova, A., Yessirkepov, M. Clinical and anamnestic features of patients with systemic vasculitis: a single-center retrospective study. Rheumatol Int 44, 687–692 (2024). https://doi.org/10.1007/s00296-024-05533-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-024-05533-4

Keywords

Search

Navigation